Wisconsin Governor Scott Walker visited Spaulding Clinical today to announce the company is eligible for up to $850,000 in tax credits through the Wisconsin Economic Development Corporation (WEDC) to facilitate the creation of 183 new full-time positions.

The employees who will be hired as a result of the tax credits will vary from skilled professionals in the medical industry to sales staff. Since January of this year, Spaulding Clinical has added five full-time hires and 10 part-time clinical staff. We project that within three years we will surpass the 183 new positions.

Read about Governor Walker’s visit to Spaulding Clinical and the full details of our tax credit eligibility.

With the most advanced technology; the integration of monitoring, recording, analyzing and reporting all in one place; and a unique specialization in cardiac safety testing for new drugs in development, we provide the highest quality results with the most accurate data and the most efficient procedures in the industry.

At Spaulding Clinical Research, we hold ourselves to the highest standards. Passionate in our pursuit of ingenious solutions that save time and money for our clients and heroic in our ambitions to ensure the health and safety of patients, Spaulding Clinical Research strives to be the Phase I facility by which all others are measured.